Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Gibson

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|June 23, 2009
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trialJ L Mega, E Braunwald, S Mohanavelu, et al.
American Heart Journal|March 29, 2001
Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 TrialJ A de Lemos, C M Gibson, E M Antman, et al.
JAMA|June 24, 2000
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarctionC P Cannon, C M Gibson, C T Lambrew, et al.
Journal of the American College of Cardiology|August 11, 1992
Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experienceJ P Carrozza, R E Kuntz, M J Levine, et al.
Circulation|March 1, 1996
TIMI frame count: a quantitative method of assessing coronary artery flowC M Gibson, C P Cannon, W L Daley, et al.
The American Journal of Cardiology|July 1, 1994
Is 40% to 70% diameter narrowing at the site of previous stenting or directional coronary atherectomy clinically significant?P C Gordon, S P Friedrich, R N Piana, et al.
American Heart Journal|June 30, 2001
Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudyV S Srinivas, C P Cannon, C M Gibson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 6, 2000
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapyJ A de Lemos, E M Antman, D A Morrow, et al.
Journal of Thrombosis and Thrombolysis|June 22, 1999
Glycoprotein IIb/IIIa receptor inhibition in interventional cardiologyC M Gibson, J L Moynihan, E N Al-Mousa, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2011
Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysisE P Navarese, G De Luca, F Castriota, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|June 23, 2009
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trialJ L Mega, E Braunwald, S Mohanavelu, et al.
American Heart Journal|March 29, 2001
Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 TrialJ A de Lemos, C M Gibson, E M Antman, et al.
JAMA|June 24, 2000
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarctionC P Cannon, C M Gibson, C T Lambrew, et al.
Journal of the American College of Cardiology|August 11, 1992
Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experienceJ P Carrozza, R E Kuntz, M J Levine, et al.
Circulation|March 1, 1996
TIMI frame count: a quantitative method of assessing coronary artery flowC M Gibson, C P Cannon, W L Daley, et al.
The American Journal of Cardiology|July 1, 1994
Is 40% to 70% diameter narrowing at the site of previous stenting or directional coronary atherectomy clinically significant?P C Gordon, S P Friedrich, R N Piana, et al.
American Heart Journal|June 30, 2001
Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudyV S Srinivas, C P Cannon, C M Gibson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 6, 2000
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapyJ A de Lemos, E M Antman, D A Morrow, et al.
Journal of Thrombosis and Thrombolysis|June 22, 1999
Glycoprotein IIb/IIIa receptor inhibition in interventional cardiologyC M Gibson, J L Moynihan, E N Al-Mousa, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2011
Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysisE P Navarese, G De Luca, F Castriota, et al.
Pageof 10